Table 1 Study characteristicsa.
Author, year (N total) | Age (Mean, SD) | Female | Family history of glaucoma | SLT arm: number of participants and description of method | Timolol arm: number of participants and description of method | Stage of glaucoma | Previous Timolol eye drops |
|---|---|---|---|---|---|---|---|
Phillipin, 2021 [5] NTotal = 201 | 66.3 (11.6) | 41.3% | 24% (same across arms) | N = 101 (191 eyes) Approximately 100 laser spots were applied to cover 360° of the trabecular meshwork. Starting energy level was 0·6 mJ, which was continuously titrated in steps of 0·1 mJ until cavitation bubbles appeared in around a third of laser spot applications. | N = 100 (191 eyes) 0·5% timolol eye drops administered twice daily | • Moderate: 48% • Advanced: 52% Note: similar % across arms | • SLT: 51 % • Timolol: 57% |
